Vanda Pharmaceuticals to Participate in the Citi 2015 Global Healthcare 1x1 Conference

Nov 04, 2015, 21:20 ET from Vanda Pharmaceuticals Inc.

WASHINGTON, Nov. 4, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda's President and CEO will participate in the Citi 2015 Global Healthcare 1x1 Conference on Thursday November 5, 2015, in New York City.

For more on Vanda Pharmaceuticals Inc., please visit

Company Contact: Jim Kelly Senior Vice President and Chief Financial Officer                                                                      Vanda Pharmaceuticals Inc. (202) 734-3428


SOURCE Vanda Pharmaceuticals Inc.